| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Kidney Institute, The University of Kansas Medical Center, Kansas City, KS, USA
2 Department of Genetics and Development Biology, University of Connecticut Health Center, Farmington, CT, USA
* To whom correspondence should be addressed. E-mail: sliu{at}kumc.edu.
Inactivating mutations of the PHEX endopeptidase, the disease-causing gene in XLH, result in increased circulating levels of FGF23, a bone-derived phosphaturic factor. To determine the causal role of FGF23 in XLH, we generated a combined Fgf23-deficient, eGFP reporter and Phex-deficient Hyp mouse model (Fgf23+/-/Hyp). eGFP expression was expressed in osteocytes embedded in bone that exhibited marked upregulation of eGFP in response to Phex deficiency, and in CD31 positive cells in bone marrow venules that expressed low eGFP levels independent of Phex. In BMSC derived from Ffg23-/-/Hyp mice, eGFP expression was also selectively increased in osteocyte-like cells within mineralization nodules and detected in low levels in CD31 positive cells. Surprisingly, eGFP expression was not increased in cell surface osteoblasts, indicating that Phex deficiency is necessary but not sufficient for increased Fgf23 expression in the osteoblast lineage. Additional factors, associated with either osteocyte differentiation and/or extracellular matrix, are necessary for Phex deficiency to stimulate Fgf23 gene transcription in bone. Regardless, the deletion of Fgf23 from Hyp mice reversed the hypophospha-temia, abnormal 1,25(OH)2D3 levels, rickets and osteomalacia associated with Phex deficiency. These results suggest that Fgf23 acts downstream of Phex to cause both the renal and bone phenotypes in Hyp mice.
This article has been cited by other articles:
|
|
 |
|
  T. Nakatani, M. Ohnishi, and M. S. Razzaque Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model FASEB J, November 1, 2009; 23(11): 3702 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Levine, C. R. Kleeman, and A. J. Felsenfeld The Journey From Vitamin D-Resistant Rickets to the Regulation of Renal Phosphate Transport Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1866 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gattineni, C. Bates, K. Twombley, V. Dwarakanath, M. L. Robinson, R. Goetz, M. Mohammadi, and M. Baum FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1 Am J Physiol Renal Physiol, August 1, 2009; 297(2): F282 - F291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Schouten, M. P Doogue, S. G Soule, and P. J Hunt Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia Ann Clin Biochem, March 1, 2009; 46(2): 167 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Razzaque FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol, March 1, 2009; 296(3): F470 - F476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Pajevic Regulation of Bone Resorption and Mineral Homeostasis by Osteocytes IBMS BoneKEy, February 1, 2009; 6(2): 63 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakatani, B. Sarraj, M. Ohnishi, M. J. Densmore, T. Taguchi, R. Goetz, M. Mohammadi, B. Lanske, and M. S. Razzaque In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis FASEB J, February 1, 2009; 23(2): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, L. Vierthaler, W. Tang, J. Zhou, and L. D. Quarles FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23 J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2342 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, J. Zhou, W. Tang, R. Menard, J. Q. Feng, and L. D. Quarles Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E254 - E261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goto, H. Komaba, and M. Fukagawa Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention NDT Plus, August 1, 2008; 1(suppl_3): iii2 - iii8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. S. Alon, R. Levy-Olomucki, W. V. Moore, J. Stubbs, S. Liu, and L. D. Quarles Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu, W. Tang, J. Zhou, L. Vierthaler, and L. D. Quarles Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1636 - E1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Razzaque and B. Lanske The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis J. Endocrinol., July 1, 2007; 194(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu and L. D. Quarles How Fibroblast Growth Factor 23 Works J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1637 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu, P. S N Rowe, L. Vierthaler, J. Zhou, and L D. Quarles Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity J. Endocrinol., January 1, 2007; 192(1): 261 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Strewler Bone Talk: Klotho and FGF23 Signaling IBMS BoneKEy, December 1, 2006; 3(12): 36 - 40. [Full Text] [PDF]
|
|
|
|
|
|
E. Schipani, S. Ferrari, N. S. Datta, L. K. McCauley, A. Vignery, T. Bellido, G. J. Strewler, C. H. Turner, Y. Jiang, and E. Seeman Meeting Report from the 28th Annual Meeting of the American Society for Bone and Mineral Research IBMS BoneKEy, November 1, 2006; 3(11): 14 - 50. [Full Text] [PDF]
|
|
|
|
|
|
L. F. Bonewald Mechanosensation and Transduction in Osteocytes. IBMS BoneKEy, October 1, 2006; 3(10): 7 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Strewler Disordered Secretion of FGF23 Links Three Disorders of Phosphate Transport IBMS BoneKEy, August 1, 2006; 3(8): 14 - 17. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
